ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

Генетические детерминанты ответа на коронавирусную инфекцию COVID-19

С. В. Поярков, В. В. Макаров, С. А. Краевой, С. М. Юдин
Информация об авторах

Центр стратегического планирования и управления медико-биологическими рисками здоровью, Москва, Россия

Статья получена: 01.07.2020 Статья принята к печати: 17.07.2020 Опубликовано online: 27.07.2020
|
  1. Zhou, P.; Yang, X.L.; Wang, X.G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.R.; Zhu, Y.; Li, B.; Huang, C.L.; et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020, 579, 270–273.
  2. Amin M, Sorour MK, Kasry A. Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV. J Phys Chem Lett. 2020;11(12):4897-4900. doi:10.1021/acs.jpclett.0c01064
  3. Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117(21):11727-11734. doi:10.1073/pnas.2003138117
  4. Hoffmann M, Kleine-Weber H, Pöhlmann S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol Cell. 2020;78(4):779-784.e5. doi:10.1016/j.molcel.2020.04.022
  5. Liu T, Luo S, Libby P, Shi GP. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients [published online ahead of print, 2020 May 26]. Pharmacol Ther. 2020;213:107587. doi:10.1016/j.pharmthera.2020.107587
  6. Gordon DE, Jang GM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing [published online ahead of print, 2020 Apr 30]. Nature. 2020;10.1038/s41586-020-2286-9. doi:10.1038/s41586-020-2286-9
  7. Zhang X, Tan Y, Ling Y, et al. Viral and host factors related to the clinical outcome of COVID-19 [published online ahead of print, 2020 May 20]. Nature. 2020;10.1038/s41586-020-2355-0. doi:10.1038/s41586-020-2355-0
  8. Zhang L, Jackson CB, Mou H, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. Preprint. bioRxiv. 2020;2020.06.12.148726. Published 2020 Jun 12. doi:10.1101/2020.06.12.148726
  9. Carlos Franco-Munoz, Diego Alejandro Alvarez-Diaz, Katherine Laiton-Donato, Magdalena Wiesner, Patricia Escandon, Jose A Usme-Ciro, Nicolas David Franco-Sierra, Astrid C Florez-Sanchez, Sergio Gomez-Rangel, Luz D Rodriguez Calderon, Juliana Barbosa Ramirez, Erika Ospitia Baez, Diana Marcela Walteros, Martha L Ospina Martinez, Marcela Mercado-Reyes Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America medRxiv 2020.06.02.20120782; doi: https://doi.org/10.1101/2020.06.02.20120782
  10. Shang, J., Ye, G., Shi, K. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221–224 (2020). https://doi.org/10.1038/s41586-020-2179-y
  11. Wang M, Li M, Ren R, et al. International Expansion of a Novel SARS-CoV-2 Mutant. J Virol. 2020;94(12):e00567-20. Published 2020 Jun 1. doi:10.1128/JVI.00567-20
  12. Bost P, Giladi A, Liu Y, et al. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients. Cell. 2020;181(7):1475-1488.e12. doi:10.1016/j.cell.2020.05.006
  13. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418. doi:10.1016/S0140-6736(20)30937-5
  14. Bandyopadhyay D, Akhtar T, Hajra A, et al. COVID-19 Pandemic: Cardiovascular Complications and Future Implications [published online ahead of print, 2020 Jun 23]. Am J Cardiovasc Drugs. 2020;1-14. doi:10.1007/s40256-020-00420-2
  15. Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities [published online ahead of print, 2020 May 27]. Cell Biol Int. 2020;10.1002/cbin.11403. doi:10.1002/cbin.11403
  16. https://www.covid19hg.org/
  17. https://www.cogconsortium.uk/
  18. Eric W. Stawiski, Devan Diwanji, Kushal Suryamohan, Ravi Gupta, Frederic A. Fellouse, J. Fah Sathirapongsasuti, Jiang Liu, Ying-Ping Jiang, Aakrosh Ratan, Monika Mis, Devi Santhosh, Sneha Somasekar, Sangeetha Mohan, Sameer Phalke, Boney Kuriakose, Aju Antony, Jagath R. Junutula, Stephan C. Schuster, Natalia Jura, Somasekar Seshagiri. Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility. bioRxiv 2020.04.07.024752; doi: https://doi.org/10.1101/2020.04.07.024752
  19. David Curtis Variants in ACE2 and TMPRSS2 genes are not major determinants of COVID-19 severity in UK Biobank subjects medRxiv 2020.05.01.20085860; doi: https://doi.org/10.1101/2020.05.01.20085860
  20. Ney Pereira Carneiro Santos, Andre Salim Khayat, Juliana Carla Gomes Rodrigues, Pablo Carmo Pinto, Gilderlanio Santana Araujo, Lucas Favacho Pastana, Jessyca Amanda Gomes Medeiros, Marianne Rodrigues Fernandes, Arthur Ribeiro dos Santos, Bruna Claudia Meireles Khayat, Fabiano Cordeiro Moreira, Andre Mauricio Ribeiro dos Santos, Paula Barauna Assumpcao, Andrea Ribeiro dos Santos, Paulo Pimentel Assumpcao, Sidney Santos TMPRSS2 variants and their susceptibility to COVID-19: focus in East Asian and European populations. medRxiv 2020.06.09.20126680; doi: https://doi.org/10.1101/2020.06.09.20126680
  21. Roberta Russo, Immacolata Andolfo, Vito Alessandro Lasorsa, Achille Iolascon, Mario Capasso Genetic analysis of the novel SARS-CoV-2 host receptor TMPRSS2 in different populations bioRxiv 2020.04.23.057190; doi: https://doi.org/10.1101/2020.04.23.057190
  22. Bullerdiek J. COVID-19 challenging cell biology. Protoplasma. 2020;257(3):619-620. doi:10.1007/s00709-020-01506-z
  23. Lopera Maya EA, van der Graaf A, Lanting P, et al. Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes. Front Genet. 2020;11:613. Published 2020 Jun 8. doi:10.3389/fgene.2020.00613
  24. Nguyen A, David JK, Maden SK, et al. Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2. J Virol. 2020;94(13):e00510-20. Published 2020 Jun 16. doi:10.1128/JVI.00510-20
  25. Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181(7):1489-1501.e15. doi:10.1016/j.cell.2020.05.015
  26. Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide Association Study of Severe Covid-19 with Respiratory Failure [published online ahead of print, 2020 Jun 17]. N Engl J Med. 2020;NEJMoa2020283. doi:10.1056/NEJMoa2020283
  27. Wu Y, Feng Z, Li P, Yu Q. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 [published online ahead of print, 2020 Jun 17]. Clin Chim Acta. 2020;509:220-223. doi:10.1016/j.cca.2020.06.026
  28. Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: Relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020;53:13-24. doi:10.1016/j.cytogfr.2020.05.009
  29. Delanghe J.R., De Buyzere M.L., Speeckaert M.M. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. European Journal of Preventive Cardiology. 2020 2047487320931305.
  30. Panda, Aditya K et al. “CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: An epidemiological investigation.” Clinica chimica acta; international journal of clinical chemistry, S0009-8981(20)30328-4. 9 Jul. 2020, doi:10.1016/j.cca.2020.07.012
  31. Chandrashekar, D. S. et al. (2020). Comparative Transcriptome Analyses Reveal Genes Associated With SARS-Cov-2 Infection of Human Lung Epithelial Cells. bioRxiv preprint. doi: https://doi.org/10.1101/2020.06.24.169268. http://biorxiv.org/cgi/content/short/2020.06.24.169268
  32. Ji HL, Zhao R, Matalon S, Matthay MA. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Physiol Rev. 2020;100(3):1065-1075. doi:10.1152/physrev.00013.2020
  33. Zhang Y, Qin L, Zhao Y, et al. Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019. J Infect Dis. 2020;222(1):34-37. doi:10.1093/infdis/jiaa224
  34. David A Dorward, Clark D Russell, In Hwa Um, Mustafa Elshani, Stuart D Armstrong, Rebekah Penrice-Randal, Tracey Millar, Chris EB Lerpiniere, Giulia Tagliavini, Catherine S Hartley, Nadine P Randall, Naomi N Gachanja, Philippe MD Potey, Alison M Anderson, Victoria L Campbell, Alasdair J Duguid, Wael Al Qsous, Ralph BouHaidar, J Kenneth Baillie, Kevin Dhaliwal, William A Wallace, Christopher OC Bellamy, Sandrine Prost, Colin Smith, Julian A Hiscox, David J Harrison, Christopher D Lucas, ICECAP.Tissue-specific tolerance in fatal Covid-19 medRxiv 2020.07.02.20145003; doi:https://doi.org/10.1101/2020.07.02.20145003